摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

triamcinolone | 308797-73-1

中文名称
——
中文别名
——
英文名称
triamcinolone
英文别名
9α-fluor-16α-hydroxyprednisolone;9α-fluoro-16α-hydroxy-prednisolone;(8S,9R,10S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
triamcinolone化学式
CAS
308797-73-1
化学式
C21H27FO6
mdl
——
分子量
394.44
InChiKey
GFNANZIMVAIWHM-SPYQQTLNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    28
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    115
  • 氢给体数:
    4
  • 氢受体数:
    7

文献信息

  • METHODS AND SYSTEMS FOR DESIGNING AND/OR CHARACTERIZING SOLUBLE LIPIDATED LIGAND AGENTS
    申请人:TUFTS MEDICAL CENTER
    公开号:US20160052982A1
    公开(公告)日:2016-02-25
    The present application provides methods for preparing soluble lipidated ligand agents comprising a ligand entity and a lipid entity, and in some embodiments, provides relevant parameters of each of these components, thereby enabling appropriate selection of components to assemble active agents for any given target of interest.
    本申请提供了制备可溶性脂质化配体药剂的方法,包括配体实体和脂质实体,并在某些实施例中提供了这些组分的相关参数,从而使得能够适当选择组分来组装出针对任何感兴趣的靶点的活性药剂。
  • AMINO ACID LIPIDS AND USES THEREOF
    申请人:Quay Steven C.
    公开号:US20080317839A1
    公开(公告)日:2008-12-25
    This disclosure provides a range of amino acid lipid compounds and compositions useful for drug delivery, therapeutics, and the diagnosis and treatment of diseases and conditions. The amino acid lipid compounds and compositions can be used for delivery of various agents such as nucleic acid therapeutics to cells, tissues, organs, and subjects.
    这份披露提供了一系列氨基酸脂类化合物和组合物,可用于药物传递、治疗、诊断和治疗疾病和病况。这些氨基酸脂类化合物和组合物可用于将各种药剂如核酸治疗剂传递到细胞、组织、器官和受试者中。
  • Amino acid lipids and uses thereof
    申请人:Quay Steven C.
    公开号:US20110177160A1
    公开(公告)日:2011-07-21
    This disclosure provides a range of amino acid lipid compounds and compositions useful for drug delivery, therapeutics, and the diagnosis and treatment of diseases and conditions. The amino acid lipid compounds and compositions can be used for delivery of various agents such as nucleic acid therapeutics to cells, tissues, organs, and subjects.
    本文披露了一系列氨基酸脂类化合物和组合物,可用于药物传递、治疗、疾病和病况的诊断和治疗。氨基酸脂类化合物和组合物可用于将各种药剂如核酸治疗剂传递至细胞、组织、器官和受试者。
  • TYROSINE-BASED LIPIDS FOR DELIVERY OF THERAPEUTICS
    申请人:Marina Biotech, Inc.
    公开号:US20160206739A1
    公开(公告)日:2016-07-21
    This disclosure provides a range of tyrosine amino acid lipid compounds and compositions useful for drug delivery, therapeutics, and the diagnosis and treatment of diseases and conditions. The amino acid lipid compounds and compositions can be used for delivery of various agents such as nucleic acid therapeutics to cells, tissues, organs, and subjects.
    本披露提供了一系列酪氨酸氨基酸脂类化合物和组合物,可用于药物输送、治疗以及疾病和病症的诊断和治疗。这些氨基酸脂类化合物和组合物可用于将各种药剂如核酸治疗剂输送至细胞、组织、器官和受试者。
  • Improved steroid esters preparation
    申请人:AB LEO
    公开号:EP0127829A2
    公开(公告)日:1984-12-12
    This invention relates to an improved steroid ester synthesis in which carbodiimides and catalytic amounts of 4-(tertiary amino)-pyridines, in combination with acid catalysts, are used as condensing agents, resulting in pure, non discoloured compounds in high yields.
    本发明涉及一种改进的甾体合成方法,在该方法中,亚胺和催化量的 4-(叔基)-吡啶与酸催化剂结合使用作为缩合剂,可获得纯度高、不变色的化合物。
查看更多

同类化合物

牛磺胺 滔罗林 棉隆 四氢-5-(2-羟基乙基)-3-甲基-2H-1,3,5-噻二嗪-2-硫酮 四氢-3,5-二甲基-4,6-二苯基-2H-1,3,5-噻二嗪-2-硫酮 噻嗪酮 7-氧杂-2-硫杂-1,5-二氮杂双环[3.3.1]壬烷 4,6-二甲基-四氢-[1,3,5]噻二嗪-2-硫酮 3-异丙基-5-苯基-1,3,5-噻二嗪-2,4-二酮 3,5-二己基-1,3,5-噻二嗪烷-2-硫酮 3,4,5,6-四氢-4,6-二甲基-2-(3-吡啶基)-2H-1,3,4-噻二嗪 2-苯甲基-1,2,6-噻重氮基己环1,1-二氧化 2-甲基-[1,2,6]噻二烷 1,1-二氧化物 2-溴乙基氨基甲酰亚胺基硫酸酯 2,6-二甲基-4-(2-甲基丙基)-2H-1,2,6-噻二嗪-3,5(4H,6H)-二酮1,1-二氧化物 2,6-二丁基-4-(2-甲基丙基)-2H-1,2,6-噻二嗪-3,5(4H,6H)-二酮1,1-二氧化 1Λ6,2,6-噻二嗪烷-1,1-二酮 (Z)-2-(叔丁基亚氨基)-3-异丙基-5-苯基-1,3,5-噻二嗪-4-酮 N-(6-sec-butyl-1,1,5-trioxo-1,2(4),5,6-tetrahydro-1λ6-[1,2,4,6]thiatriazin-3-yl)-N-propyl-acetamide 6-Butyl-1,1-dioxo-1λ6-[1,2,6]thiadiazinan-3-one 2,3,6-trimethyl-1,1-dioxo-1λ6-thiomorpholin-4-ylamine 5-methyl-1,3-bis-methylsulfanylmethyl-[1,3,5]triazinan-2-one 6-dimethylamino-3-methyl-2,3-dihydro-[1,3,5]thiadiazine-4-thione 6-Isopropyl-1,1-dioxo-1λ6-[1,2,6]thiadiazinan-3-one 1,3-dimethyl-5,5-dioxo-(3ar,6ac)-hexahydro-5λ6-thieno[3,4-d]imidazol-2-one 2-Allyl-5-chlorcarbonyl-1,2,5-thiadiazolidin-1,1-dioxid 3,5-diundecyl-[1,3,5]thiadiazinane-2-thione 2,2-Dibutyl-5,8-dimethyl-[1,3,5,8,2]dithiadiazastannonane-4,9-dithione 2-Nitrosoimino-3-aethyl-thiazolidin N-allyl-4-hydroxy-5-methylene-1,2-thiazine-tetrahydro-1,1-dioxide 2,4-Dicyclohexyl-6-methyl-1,1-dioxo-1λ6-[1,2,4,6]thiatriazinane-3,5-dione 6-benzyl-3-isopropyl-2-phenyl-2,3-dihydro-[1,3,5]thiadiazin-4-one (1,1,3,5-tetraoxo-1λ6-[1,2,4,6]thiatriazinan-4-yl)-phosphonic acid dimethyl ester 7-phenyl-1,4,6,7-tetrahydro-thiazolo[5,4-d]pyrimidine-2,5-dione 1,3-bis-(thiophene-2-sulfonylmethyl)-imidazolidin-2-one triamcinolone N--propansultam-(1,3) 4-Methyl-2H-1,2,4-thiadiazin-3,5(4H,6H)-dion-1,1-dioxid 3-Ethyl-3,4-dihydro-1,3-thiazin-2-thion 3,6-diethyl-tetrahydro-[1,3,6]thiadiazepine-2-thione 3-(3-cyclopentyl-2-thioxo-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazin-5-yl)propanoic acid 2,5-bis-methanesulfonyl-[1,2,5]thiadiazolidine 1,1-dioxide (2aS)-3-benzyl-5ξ-methoxy-(2ar,7ac,7bc)-hexahydro-1-thia-3,4a-diaza-cyclopenta[cd]inden-4-one 8,13-diaza-6,6-dimethyl-2-thia-18,14-seco-gona-5(10),9(11)-diene-14,17-dione 2-butyl-4-methyl-5-methylene-1,1-dioxo-isothiazolidin-4-ol (2S)-1-(1,1-dioxo-1,2,6-thiadiazinan-2-yl)-3,3-dimethylbutan-2-amine;hydrochloride 4-cyclohexyl-2-phenyl-[1,2,4]thiadiazinane 1,1-dioxide 3-Benzyl-1,3,5-tetrahydrothiadiazinthion-(2) 16-Hydroxy-9alpha-fluoro-delta1-hydrocortisone [Au(dibenzyldithiocarbamate)(2-thia-1,3,5-triaza-7-phosphaadamantane-2,2-dioxide)]